About this source
- Kind
- Research
- Design
- RCT, Human clinical trial
- Population
- Human healthy adults, 40 volunteers in four cohorts of 10, Phase 1
- Sample size
- 40
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Phase 1 safety and pharmacokinetic study in healthy people. Intravenous route, a different route from the eye drops and topical products in the efficacy trials. Verified from the Europe PMC abstract record.
Cited in
Phase 1, 40 volunteers (full-length thymosin beta-4)
TB-500 · Safety finding
Phase 1, 40 healthy volunteers
Thymosin beta-4 · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.